Dongfang Liu - Feb 29, 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
Feb 29, 2024
Transactions value $
$0
Form type
4
Date filed
3/4/2024, 04:27 PM
Previous filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NUVB Class A Common Stock 6K Feb 29, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +500K $0.00 500K Feb 29, 2024 Class A Common Stock 500K $1.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,000 shares acquired on May 19, 2023 and 3,000 shares acquired on November 17, 2023 under the Issuer's 2021 Employee Stock Purchase Plan.
F2 Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.